Alternative splicing of the neurofibromatosis type I pre-mRNA
- 31 October 2011
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 32 (2), 131-138
- https://doi.org/10.1042/bsr20110060
Abstract
NF1 (neurofibromatosis type I) is a common genetic disease that affects one in 3500 individuals. The disease is completely penetrant but shows variable phenotypic expression in patients. NF1 is a large gene, and its pre-mRNA undergoes alternative splicing. The NF1 protein, neurofibromin, is involved in diverse signalling cascades. One of the best characterized functions of NF1 is its function as a Ras-GAP (GTPase-activating protein). NF1 exon 23a is an alternative exon that lies within the GAP-related domain of neurofibromin. This exon is predominantly included in most tissues, and it is skipped in CNS (central nervous system) neurons. The isoform in which exon 23a is skipped has 10 times higher Ras-GAP activity than the isoform in which exon 23a is included. Exon 23a inclusion is tightly regulated by at least three different families of RNA-binding proteins: CELF {CUG-BP (cytosine-uridine-guanine-binding protein) and ETR-3 [ELAV (embryonic lethal abnormal vision)-type RNA-binding protein]-like factor}, Hu and TIA-1 (T-cell intracellular antigen 1)/TIAR (T-cell intracellular antigen 1-related protein). The CELF and Hu proteins promote exon 23a skipping, while the TIA-1/TIAR proteins promote its inclusion. The widespread clinical variability that is observed among NF1 patients cannot be explained by NF1 mutations alone and it is believed that modifier genes may have a role in the variability. We suggest that the regulation of alternative splicing may act as a modifier to contribute to the variable expression in NF1 patients.Keywords
This publication has 100 references indexed in Scilit:
- Expansion of the eukaryotic proteome by alternative splicingNature, 2010
- The pathobiology of splicingThe Journal of Pathology, 2009
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approachesNature Reviews Molecular Cell Biology, 2009
- Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Human Molecular Genetics, 2009
- Alternative isoform regulation in human tissue transcriptomesNature, 2008
- Diverse molecular functions of Hu proteinsCellular and Molecular Life Sciences, 2008
- Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathwayHuman Molecular Genetics, 2008
- Neuronal regulation of alternative pre-mRNA splicingNature Reviews Neuroscience, 2007
- Splicing in disease: disruption of the splicing code and the decoding machineryNature Reviews Genetics, 2007
- Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicingThe EMBO Journal, 2007